International Pharma Associations Lay Principles For Publishing Trial Data, Regardless Of Outcome
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Multinational pharmaceutical companies may start submitting for publication the results of more clinical trials, whether they are successful or not, as part of a new set of principles endorsed by industry associations around the world